100 COLUMBIA STREET, ALISO VIEJO, CA
Earnings Release
ANNOUNCES APPOINTMENTS OF AZIZ MOTTIWALA AS CHIEF EXECUTIVE OFFICER AND RON KURTZ, MD AS CHIEF MEDICAL OFFICER
Announce Collaboration to Develop Adjustable PCIOLs
ANNOUNCES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS AND PRODUCT PIPELINE UPDATES FOLLOWING STRATEGIC COLLABORATION AGREEMENT
Election Results from 2026 Annual Meeting; Three Directors Re-Elected
REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES FULL-YEAR SALES OUTLOOK
Annual Report to Security Holders
Amended material disclosure
Q2
Q1
FY 2024
Q3
FY 2023
SC TO-I
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Tender Offer Statement by Issuer
Specialized Disclosure Report
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement